Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 29.12
-2.02 (-6.49%)
Apr 21, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 16.13 billion as of April 20, 2026.
Market Cap
16.13B
Enterprise Value
15.40B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.12
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has increased from 13.62B to 16.13B, an increase of 18.40%. That is a compound annual growth rate of 39.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 16.13B | -55.83% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunshine Lake Pharma | 25.36B |
| Grand Pharmaceutical Group | 23.67B |
| The United Laboratories International Holdings | 19.81B |
| Fujian Haixi Pharmaceuticals | 15.36B |
| CanSino Biologics | 14.08B |
| Consun Pharmaceutical Group | 13.73B |
| Sihuan Pharmaceutical Holdings Group | 12.03B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |